Tristel Earnings Date & Estimates

Tristel (OTCMKTS:TSNLF) is a United Kingdom-based infection prevention company that develops, manufactures and supplies disinfectants for healthcare and other specialist applications. Its products are designed to help prevent the transmission of infection through the decontamination of medical instruments, equipment and surfaces.

The company’s product range includes chlorine dioxide-based disinfectants and related cleaning systems for medical devices such as ultrasound probes, endoscopes and other equipment that may not be suitable for conventional automated reprocessing. Tristel also supplies wipes, foams and other products used in clinical environments, with solutions intended to support infection-control procedures across hospitals, clinics and healthcare facilities.

Tristel was established in the United Kingdom in the 1990s and has expanded from its domestic market to serve customers internationally through distributors and direct sales channels. The company is headquartered in Cambridgeshire, England, and has been led by Chief Executive Officer Paul Swinney, who has been associated with the business for many years. Tristel plc’s ordinary shares are listed on London’s AIM market, while its securities also trade in the United States over the counter under the symbol TSNLF.